Hims & Hers Health Inc

3.08.2026 г., 23:41 ч. UTC

Hims & Hers Health shares are higher in after-market trading, following positive growth insights despite facing a lawsuit from the Federal Trade Commission.

31.07.2026 г., 19:36 ч. UTC

Hims & Hers Health Inc is trading higher amid social media discussions about potential undervaluation, despite facing a lawsuit over user health data practices.

30.07.2026 г., 20:11 ч. UTC

Hims & Hers Health Inc shares are higher today amid high trading volume. Broader economic data showed mixed signals, contributing to market volatility.

29.07.2026 г., 23:16 ч. UTC

Hims & Hers Health shares declined in after-market trading amid legal challenges from the FTC over alleged privacy violations and a securities fraud investigation.

28.07.2026 г., 23:41 ч. UTC

Hims & Hers Health shares declined in after-market trading, remaining near the lower end of their one-month range amid broader market pressures from Asian tech losses.

27.07.2026 г., 20:03 ч. UTC

Hims & Hers Health shares rise amid FDA committee's endorsement of peptides, seen as a significant step toward market access for treatments.

24.07.2026 г., 23:16 ч. UTC

Hims & Hers Health Inc. shares rose after-hours following positive votes from an FDA/HHS panel on six peptides, with a final decision expected in up to 12 months.

23.07.2026 г., 23:26 ч. UTC

Hims & Hers Health Inc shares are higher after an FDA advisory panel recommended easing restrictions on a popular peptide and Canaccord reiterated a Buy rating.

22.07.2026 г., 23:16 ч. UTC

Hims & Hers Health shares declined to about $31.66 after mixed options sentiment, with calls outpacing puts amid lighter trading volume.

21.07.2026 г., 17:31 ч. UTC

Hims & Hers Health Inc shares are declining amid an investigation into potential wrongdoing and concerns over FDA approval of key peptides.

20.07.2026 г., 18:37 ч. UTC

Hims & Hers Health Inc. is trading higher amid broader market dynamics, despite earlier pulling back from a session high.